@article{b8452a294fae49a3a0a0974093f83798,
title = "NCCN GUIDELINES{\textregistered} INSIGHTS CE Gastrointestinal Stromal Tumors, Version 2.2022 Featured Updates to the NCCN Guidelines",
abstract = "Gastrointestinal stromal tumors (GIST) are the most common type of soft tissue sarcoma that occur throughout the gastrointestinal tract. Most of these tumors are caused by oncogenic activating mutations in the KIT or PDGFRA genes. The NCCN Guidelines for GIST provide recommendations for the diagnosis, evaluation, treatment, and follow-up of patients with these tumors. These NCCN Guidelines Insights summarize the panel discussion behind recent important updates to the guidelines, including revised systemic therapy options for unresectable, progressive, or metastatic GIST based on mutational status, and updated recommendations for the management of GIST that develop resistance to specific tyrosine kinase inhibitors.",
author = "{von Mehren}, Margaret and Kane, {John M.} and Riedel, {Richard F.} and Sicklick, {Jason K.} and Pollack, {Seth M.} and Mark Agulnik and Bui, {Marilyn M.} and Janai Carr-Ascher and Edwin Choy and Mary Connelly and Sarah Dry and Ganjoo, {Kristen N.} and Gonzalez, {Ricardo J.} and Ashley Holder and Jade Homsi and Vicki Keedy and Kelly, {Ciara M.} and Edward Kim and David Liebner and Martin McCarter and McGarry, {Sean V.} and Mesko, {Nathan W.} and Christian Meyer and Pappo, {Alberto S.} and Parkes, {Amanda M.} and Petersen, {Ivy A.} and Matthew Poppe and Scott Schuetze and Jacob Shabason and Spraker, {Matthew B.} and Melissa Zimel and Bergman, {Mary Anne} and Hema Sundar and Hang, {Lisa E.}",
note = "Publisher Copyright: {\textcopyright} National Comprehensive Cancer Network, Inc. 2022.",
year = "2022",
month = nov,
doi = "10.6004/jnccn.2022.0058",
language = "English (US)",
volume = "20",
pages = "1204--1214",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "11",
}